Immunic (IMUX) Assets (2013 - 2026)
Immunic (IMUX) posted Assets of $189.7 million for Q1 2026, up 688.88% sequentially from $24.1 million in Q4 2025, and up 824.89% YoY from $20.5 million in Q1 2025.
Immunic (IMUX) Assets (2013 - 2026) Analysis & Trends
Immunic has reported Assets for 14 years, with the latest figure at $189.7 million in Q1 2026.
- Quarterly Assets rose 824.89% year-over-year to $189.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $189.7 million (up 824.89% YoY) and the FY2025 annual result came in at $24.1 million, down 41.15% from the prior year.
- Assets improved to $189.7 million in Q1 2026 per IMUX's latest filing, from $24.1 million in the prior quarter.
- Over five years, Assets peaked at $189.7 million in Q1 2026 and troughed at $20.5 million in Q1 2025.
- A 5-year average of $87.6 million and a median of $86.5 million in 2024 frame the typical range for Assets.
- The sharpest annual moves came in 2025 and 2026: Assets slumped 80.3% in 2025, then soared 824.89% in 2026.
- Over 5 years, Assets stood at $127.8 million in 2022, then plunged by 57.5% to $54.3 million in 2023, then declined by 24.74% to $40.9 million in 2024, then tumbled by 41.15% to $24.1 million in 2025, then soared by 688.88% to $189.7 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $189.7 million, $24.1 million, and $40.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Immunic | 682.77 Mn | 682.77 Mn | - | 159.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 159.17 Mn |
| Mar 31, 2026 | 189.74 Mn |
| Dec 31, 2025 | 24.05 Mn |
| Sep 30, 2025 | 40.70 Mn |
| Jun 30, 2025 | 61.43 Mn |
| Mar 31, 2025 | 20.52 Mn |
| Dec 31, 2024 | 40.87 Mn |
| Sep 30, 2024 | 64.76 Mn |
| Jun 30, 2024 | 86.49 Mn |
| Mar 31, 2024 | 104.16 Mn |
| Dec 31, 2023 | 54.30 Mn |
| Sep 30, 2023 | 66.98 Mn |
| Jun 30, 2023 | 88.74 Mn |
| Mar 31, 2023 | 108.87 Mn |
| Dec 31, 2022 | 127.75 Mn |
| Sep 30, 2022 | 121.08 Mn |
| Jun 30, 2022 | 138.66 Mn |
| Mar 31, 2022 | 149.92 Mn |
| Dec 31, 2021 | 139.10 Mn |
| Sep 30, 2021 | 156.76 Mn |